Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elaine Siegfried

Dermatology Saint Louis, MO Medical Doctor

NPI 1508975160 CMS profile 113545

1465 S Grand Blvd, Saint Louis, MO 63104

Open in the dashboard

General payments

$856,092

431 records reported · program years 2019–2025

Research payments

$200,534

Paid to them · 274 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,325,378 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Elaine Siegfried of Saint Louis, MO is reported in the CMS Open Payments database as having received $856,092 across 431 general payments and $200,534 in research payments paid to them. Separately, studies naming them as principal investigator received $1,325,378 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $91,637 48
2025 Research $21,435 34
2024 General $202,286 79
2024 Research $32,252 51
2023 General $84,880 53
2023 Research $31,231 33
2022 General $161,667 67
2022 Research $43,702 64
2021 General $72,412 31
2021 Research $38,665 45
2020 General $79,015 34
2020 Research $18,884 23
2019 General $164,194 119
2019 Research $14,366 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elaine Siegfried
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Elaine Siegfried were reported at $91,637. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Elaine Siegfried Dermatology median Middle half National median
2019 $164,194 $454 $129–$1,240 $163
2020 $79,015 $235 $81–$756 $114
2021 $72,412 $377 $108–$1,108 $132
2022 $161,667 $514 $143–$1,391 $149
2023 $84,880 $607 $159–$1,674 $160
2024 $202,286 $751 $204–$1,903 $164
2025 $91,637 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $388,423 125 payments
  2. Regeneron Healthcare Solutions, Inc. $165,053 149 payments
  3. Sanofi-Aventis U.S. LLC $128,401 23 payments
  4. Regeneron Pharmaceuticals, Inc. $35,696 24 payments
  5. Dermavant Sciences, Inc. $27,525 21 payments
  6. LEO Pharma Inc. $22,626 12 payments
  7. Pfizer Inc. $18,746 16 payments
  8. AbbVie, Inc. $17,967 12 payments
  9. Ucb SA $16,709 11 payments
  10. Novartis Pharmaceuticals Corporation $6,652 4 payments
  11. Other $28,296 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $411,322 95 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $336,613 74 payments
  3. Travel and Lodging $90,801 119 payments
  4. Honoraria $8,690 4 payments
  5. Food and Beverage $8,519 135 payments
  6. Education $147 4 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $297,715 75 payments
  2. DUPIXENT Inflammation And Immunology $165,623 148 payments
  3. DUPIXENT Immunology $44,860 22 payments
  4. TAPINAROF $27,512 20 payments
  5. Bimzelx $9,480 5 payments
  6. Cimzia $7,229 6 payments
  7. DUPIXENT Immunology And Inflammation $5,147 6 payments
  8. EUCRISA $4,021 5 payments
  9. Zoryve $3,929 10 payments
  10. YCANTH $3,812 3 payments
  11. Other $6,444 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $169,639 237 payments
  2. Genzyme Corporation $13,750 33 payments
  3. Novartis Pharmaceuticals Corporation $9,225 2 payments
  4. Eli Lilly and Company $4,720 1 payment
  5. Pfizer Inc. $3,200 1 payment

Records

705 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record